Provided by Tiger Trade Technology Pte. Ltd.

Heron Therapeutics

0.3182
+0.00922.98%
Post-market: 0.32000.0018+0.57%19:58 EDT
Volume:3.02M
Turnover:959.46K
Market Cap:60.14M
PE:-1.73
High:0.3330
Open:0.3106
Low:0.3100
Close:0.3090
52wk High:1.58
52wk Low:0.2975
Shares:189.00M
Float Shares:147.00M
Volume Ratio:1.09
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1842
EPS(LYR):-0.1211
ROE:-2408.88%
ROA:-2.80%
PB:10.27
PE(LYR):-2.63

Loading ...

Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC) and Heron Therapeutics (HRTX)

TIPRANKS
·
Aug 18

Allstate, CHMI, HRTX, AppLovin, BCE Trending With Analysts

TIPRANKS
·
Aug 15

Seer Q2 Revenue Falls 23% as Funding Slows

Reuters
·
Aug 12

HC Wainwright Downgrades Heron Therapeutics to Neutral From Buy

MT Newswires Live
·
Aug 11

Xtant Medical Q2 Revenue Falls on Asset Sales and Lost License Revenue

Reuters
·
Aug 11

Fennec Pharmaceuticals Q2 Sales Rise on Pedmark Demand

Reuters
·
Aug 11

Heron Therapeutics Inc : H.c. Wainwright Cuts to Neutral from Buy

THOMSON REUTERS
·
Aug 11

Heron Therapeutics Faces Nasdaq Delisting Risk as Share Price Falls Below $1 Threshold

TIPRANKS
·
Aug 11

TELA Bio Q2 Revenue Falls on Lower OviTex PRS Volumes, Withdraws Outlook

Reuters
·
Aug 11

Harrow Q2 Revenue Slightly Beats Estimates

Reuters
·
Aug 11

Mesa Labs Q1 Revenue Rises as Calibration, Biopharma Units Grow

Reuters
·
Aug 11

Septerna Q2 Revenue Beats Analyst Estimates, Driven by Novo Nordisk Partnership

Reuters
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Aug 11

Heron Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Ireland's Theravance Biopharma Q2 Revenue Rises 11% but Misses Estimates

Reuters
·
Aug 10

Heron Q2 FY26 Net Loss Widens to $5.49 Million; Net Sales Rise 1.3% to $37.67 Million

Reuters
·
Aug 10

Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook

Reuters
·
Aug 10

Heron Therapeutics Amends Hercules Capital Credit Facility, Cuts Principal by $13.5 Million

Reuters
·
Aug 10

Heron Therapeutics Q2 EPS $(0.03) Misses $(0.01) Estimate, Sales $37.666M Miss $42.200M Estimate

Benzinga Earnings
·
Aug 10

Heron Therapeutics - Withdraws Full-Year 2026 Financial Guidance

THOMSON REUTERS
·
Aug 10